Medacta Group S.A.
MEDGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.41 | 14.84 | -3.36 | 1.24 |
| FCF Yield | 0.15% | -0.47% | 0.66% | 0.30% |
| EV / EBITDA | 11.36 | 14.17 | 15.93 | 26.86 |
| Quality | ||||
| ROIC | 10.87% | 9.98% | 11.78% | 15.30% |
| Gross Margin | 67.64% | 68.10% | 69.83% | 71.94% |
| Cash Conversion Ratio | 1.47 | 1.59 | 1.59 | 1.05 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.55% | 12.04% | 13.06% | 5.34% |
| Free Cash Flow Growth | 134.57% | -168.52% | 36.75% | -76.57% |
| Safety | ||||
| Net Debt / EBITDA | 1.31 | 1.51 | 1.29 | 1.15 |
| Interest Coverage | 12.09 | 10.90 | 16.78 | 17.08 |
| Efficiency | ||||
| Inventory Turnover | 0.82 | 0.76 | 0.82 | 0.75 |
| Cash Conversion Cycle | 447.14 | 459.84 | 429.97 | 454.34 |